These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30939150)

  • 1. Impact of universal drug susceptibility testing and effective management of multidrug-resistant tuberculosis in Taiwan.
    Lee PH; Chan PC; Peng YT; Chu PW; Wu MH; Jou R; Yu MC; Lin CJ; Huang YW; Chien ST; Lee JJ; Chiang CY
    PLoS One; 2019; 14(4):e0214792. PubMed ID: 30939150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment Outcomes of Multidrug-Resistant Tuberculosis in Taiwan: Tackling Loss to Follow-up.
    Yu MC; Chiang CY; Lee JJ; Chien ST; Lin CJ; Lee SW; Lin CB; Yang WT; Wu YH; Huang YW
    Clin Infect Dis; 2018 Jul; 67(2):202-210. PubMed ID: 29394358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decline in rates of acquired multidrug-resistant tuberculosis after implementation of the directly observed therapy, short course (DOTS) and DOTS-Plus programmes in Taiwan.
    Chien JY; Lai CC; Tan CK; Chien ST; Yu CJ; Hsueh PR
    J Antimicrob Chemother; 2013 Aug; 68(8):1910-6. PubMed ID: 23580558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of treating multidrug-resistant tuberculosis.
    Resch SC; Salomon JA; Murray M; Weinstein MC
    PLoS Med; 2006 Jul; 3(7):e241. PubMed ID: 16796403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug resistance and associated genetic mutations among patients with suspected MDR-TB in Uttar Pradesh, India.
    Jain A; Singh PK; Chooramani G; Dixit P; Malhotra HS
    Int J Tuberc Lung Dis; 2016 Jul; 20(7):870-5. PubMed ID: 27287637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reduction in anti-tuberculosis drug resistance after the implementation of the national "STOP TB" program in central Taiwan, 2003-2007.
    Huang WC; Chen CH; Huang CC; Wu KM; Chiou CS; Lin CF; Chen JH; Shen GH
    Jpn J Infect Dis; 2013; 66(2):89-95. PubMed ID: 23514903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania.
    Juma SP; Maro A; Pholwat S; Mpagama SG; Gratz J; Liyoyo A; Houpt ER; Kibiki GS; Mmbaga BT; Heysell SK
    BMC Infect Dis; 2019 Feb; 19(1):129. PubMed ID: 30732572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of a government-organized and hospital-initiated treatment for multidrug-resistant tuberculosis patients--a retrospective cohort study.
    Chan PC; Huang SH; Yu MC; Lee SW; Huang YW; Chien ST; Lee JJ;
    PLoS One; 2013; 8(2):e57719. PubMed ID: 23451263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
    van Maaren PJ
    Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug-resistant tuberculosis in the Northern Territory: A 10-year retrospective case series.
    Judge D; Krause V
    Commun Dis Intell Q Rep; 2016 Sep; 40(3):E334-E339. PubMed ID: 28278406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China.
    Xia H; van den Hof S; Cobelens F; Zhou Y; Zhao B; Wang S; Zhao Y
    BMC Infect Dis; 2020 Jan; 20(1):19. PubMed ID: 31910878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional Drug Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Korea: Implications for Regimen Design.
    Mok JH; Kang BH; Lee T; Lee HK; Jang HJ; Cho YJ; Jeon D
    J Korean Med Sci; 2017 Apr; 32(4):636-641. PubMed ID: 28244290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission of multi-drug resistant tuberculosis in Mongolia is driven by Beijing strains of Mycobacterium tuberculosis resistant to all first-line drugs.
    Gurjav U; Erkhembayar B; Burneebaatar B; Narmandakh E; Tumenbayar O; Hill-Cawthorne GA; Marais BJ; Sintchenko V
    Tuberculosis (Edinb); 2016 Dec; 101():49-53. PubMed ID: 27865397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug-resistant tuberculosis among previously treated patients in the Philippines.
    Gler MT; Macalintal LE; Raymond L; Guilatco R; Quelapio MI; Tupasi TE
    Int J Tuberc Lung Dis; 2011 May; 15(5):652-6. PubMed ID: 21756517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in drug-resistant tuberculosis after the implementation of the DOTS strategy in Shenzhen, China, 2000-2013.
    Zhu L; Yang YZ; Guan HY; Cheng SM; Jin YY; Tan WG; Wu QF; Liu XL; Zhao MG; Lu ZH; Jia ZW
    Int J Tuberc Lung Dis; 2017 Jul; 21(7):759-765. PubMed ID: 28633700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of an Xpert-based diagnostic algorithm for the rapid detection of drug-resistant tuberculosis among high-risk populations in a low-incidence setting.
    Chiang TY; Fan SY; Jou R
    PLoS One; 2018; 13(7):e0200755. PubMed ID: 30011319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug-resistant tuberculosis of the spine--is it the beginning of the end? A study of twenty-five culture proven multidrug-resistant tuberculosis spine patients.
    Pawar UM; Kundnani V; Agashe V; Nene A; Nene A
    Spine (Phila Pa 1976); 2009 Oct; 34(22):E806-10. PubMed ID: 19829244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological trends and outcomes of extensively drug-resistant tuberculosis in Shandong, China.
    He XC; Tao NN; Liu Y; Zhang XX; Li HC
    BMC Infect Dis; 2017 Aug; 17(1):555. PubMed ID: 28793873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly successful treatment outcome of multidrug-resistant and genetic diversity of multidrug-resistant Mycobacterium tuberculosis strains in Rwanda.
    Muvunyi CM; Ngabonziza JCS; Uwimana I; Harelimana JD; Mucyo Y; Sebatunzi OR; Muvunyi TZ; Seruyange E; Masaisa F; Mazarati JB; Gasana M
    Trop Med Int Health; 2019 Jul; 24(7):879-887. PubMed ID: 31066112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of second-line antituberculosis drug susceptibilities of multidrug-resistant Mycobacterium tuberculosis complex isolates by E-test method].
    Şimşek H; Tarhan G; Cesur S
    Mikrobiyol Bul; 2015 Jan; 49(1):47-55. PubMed ID: 25706730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.